Sa prognosi de su tumore a sos purmones dipendet dae medas fatores, intre sos cales s'istàdiu de su tumore, su tipu de tumore a sos purmones e s'istadu generale de salude de su malàidu.
Su tumore a su purmone non de tzèllulas minores, chi est su tipu prus comunu, tenet unu tassu de subravivèntzia a 5 annos de belle su 18% pro totu sos istàdios cumbinados.
S'arriscu de mortalidade pro sos tumores de su pacu, chi est prus pagu comunu, est de su 7% pro totu sas fases.
Est de importu a ammentare chi custas sunt istatìsticas generales e sos resurtados individuales podent variare.
Sas opziones de tratamentu e sos progressos in meighina sighint a megiorare, e medas malàidos podent bìvere prus a longu e tènnere una calidade de vida mezus cun curas e gestione adeguadas.
Martini B: [Lung cancer--epidemiology, prognosis and therapy]. Med Monatsschr Pharm. 2006, 29 (6): 217-21.
Zou T, Liu JY, She L, Yin JY, Li X, Li XP, Zhou HH, Chen J, Liu ZQ: The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Front Pharmacol. 2020, 11 (): 1029.
Li L, Zhou Q, Luo D, Xu Y, Yang H, Zhang S, Li A, Li H, Lv C: [A study on the relationship between lung cancer cell apoptosis and prognosis in patients with human non-small cell lung cancer.]. Zhongguo Fei Ai Za Zhi. 1998, 1 (2): 70-3.
Feng YY, Yang Y, Wang YY, Bai XX, Hai P, Zhao R: [Hypomethylation of DAPL1 associated with prognosis of lung cancer patients with EGFR Del19 mutation]. Zhonghua Zhong Liu Za Zhi. 2021, 43 (12): 1264-1268.
Xiao Y, Zhu S, Yin W, Liu X, Hu Y: IGFBP-4 expression is adversely associated with lung cancer prognosis. Oncol Lett. 2017, 14 (6): 6876-6880.
Lang J, Zhao Q, He Y, Yu X: Bone turnover markers and novel biomarkers in lung cancer bone metastases. Biomarkers. 2018, 23 (6): 518-526.
['Disclaimer: mèdicu']
['Custu giassu est fatu po istudiare e informae sa zente e non est unu giassu de consultatzione o de azudu.']
['Sa informassione frunida no est de impreare pro diagnosticare o curare unu problema de salude o una maladia, e sos chi chircant consìgios mèdicos personales si depent cuntatare cun unu mèdicu autorizadu.']
["S'arricordaus ca sa retza neurali chi creat rispostas a is pregontas est imperfeta candu si chistionat de nùmerus, po nai su nùmeru de personas chi tenint una maladia."]
["Chirca semper su parre de su dotore tuo o de un'àteru dotore cualificadu pro cale si siat cunditzione mèiga. No disconnoscas mai su parre de unu professionista mèigu o non bi tardes a l'agatare pro carchi cosa chi as lèghidu in custu situ. Si tenes pensamentos de tènnere un'emergèntzia mèiga, telefona a su 911 o bae a su pronto soccorsu prus acanta."]
['Disclaimer: deretu de autore']
['Sa Digital Millennium Copyright Act de su 1998, 17 U.S.C. § 512 (sa DMCA) donat unu recursu a is propietàrius de deretus de autori chi pensant chi unu materiali chi aparit in Internet ofendet is deretus insoru assuta de sa lei de su deretu de autori de is IUA. ']
["Si creis de bona fidi chi calicunu cuntènniu o materiale postu a disponimentu in su giassu o in is servìtzios nostros at ofesu is deretus de autore tuos, tui (o s'agenti tuo) nos podes imbiare una comunicatzioni domandendi de nde bogare su cuntènniu o su materiale, o de nde blocare s'atzessu."]
['Sos annùntzios depent èssere imbiados pro iscrittu pro mèdiu de posta eletrònica (càstia sa setzione "Cuntatu" pro s\'indiritzu de posta eletrònica). ']
["Sa DMCA recheret chi sa notìfica tua de sa presunta violatzione de copyright incluat sas informatziones sighentes: (1) descritzione de s'òpera amparada dae copyright chi est ogetu de sa presunta violatzione; (2) descritzione de su chi si narat chi est unu cuntènnidu chi diat pòdere èssere istadu violadu e informatziones bastantes pro nos permìtere de localizare su cuntènnidu; (3) informatziones pro ti cuntatare, intre cales s'indiritzu tuo, su nùmeru de telèfono e s'indiritzu de posta eletrònica; (4) una decraratzione tua pro nàrrere chi tenes bona fide chi su cuntènnidu de sa manera chi ses lamentende non est autorizadu dae su mere de su copyright, dae s'agente suo o dae cale si siat lege."]
["5) una decraratzione firma tua, suta pena de perjuria, chi is informatziones in sa notìfica sunt acuradas e chi tenes s'autorizatzione pro aplicare is deretos de autore chi sunt istados violados; "]
['e (6) una firma fìsica o eletrònica de su mere de su deretu de autore o de una persone autorizada a agire a nùmene suo. ']
['Si non ponis totu is informatzionis de prima podit essi chi su protzedimentu ti siat tardau.']
['Contatu']
['Manda·nos una mail cun cale si siat dimanda o sugerimentu.']
What is prognosis of lung cancer?
The prognosis of lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the overall health of the patient.
Non-small cell lung cancer, which is the most common type, has a 5-year survival rate of about 18% for all stages combined.
However, if the cancer is caught early, the 5-year survival rate can be as high as 57%. Small cell lung cancer, which is less common, has a 5-year survival rate of about 7% for all stages combined.
It is important to note that these are general statistics and individual outcomes may vary.
Treatment options and advancements in medicine continue to improve, and many patients can live longer and have a better quality of life with proper care and management.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Prus o mancu']
['BioMedLib impreat elaboradores automatizados (algoritmos de imparu automàticu) pro generare parigas de dimandas e rispostas.']
['Incumentzamus cun 35 milliones de publicatziones biomèdicas de PubMed/Medline. E puru, pàginas web de RefinedWeb.']
